Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 18 Aug 23 424B5 Prospectus supplement for primary offering
- 6 Dec 22 424B3 Prospectus supplement
- 6 Dec 22 424B3 Prospectus supplement
- 24 Aug 22 424B3 Prospectus supplement
- 19 May 22 424B5 Prospectus supplement for primary offering
- 28 Feb 22 424B5 Prospectus supplement for primary offering
- 24 Feb 22 424B5 Prospectus supplement for primary offering
- 28 Dec 21 424B5 Prospectus supplement for primary offering
- 3 Sep 21 EFFECT Notice of effectiveness
-
2 Sep 21 S-3/A Shelf registration (amended)
- 16 Feb 21 S-3 Shelf registration
BXRXQ similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Baudax Bio, Inc.:
We consent to the use of our report dated February 16, 2021, with respect to the consolidated and combined financial statements of Baudax Bio Inc. incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
Philadelphia, Pennsylvania
September 2, 2021